Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. JEHSX: which is better?

Bottom line

PRHSX vs JEHSX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and JEHSX (Health Sciences Trust) have nearly the same top holdings — their top 25 positions are about 97% the same by weight.

PRHSX is cheaper at 0.83% vs 1.04% — a difference of $21 a year per $10,000 invested.

Over five years, PRHSX returned +4.2% a year vs +4.2% for JEHSX.

Updated Nov 19, 2026

PRHSX vs JEHSX side by side

PRHSXJEHSX
TypeMutual fundMutual fund
Fund familyT. Rowe PriceJohn Hancock
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%1.04%
Annual cost per $10k$83$104
10-yr cost on $10k (prospectus)$1,025$1,282
Max front load——
12b-1 fee—0.05%
1-yr return+17.7%+19.5%
5-yr return (annualized)+4.2%+4.2%
10-yr return (annualized)+9.1%+8.7%
Best quarter+23.5%+23.6%
Worst quarter−15.8%−16.1%
Net assets (fund)$11.9B$251.3M
Number of holdings279173
Portfolio turnover62%68%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXJEHSXDifference
2025+17.7%+19.5%−1.8%
2024+1.8%+1.8%+0.0%
2023+3.1%+4.3%−1.2%
2022−12.2%−13.1%+0.9%
2021+13.3%+11.2%+2.1%
2020+30.1%+27.2%+3.0%
2019+29.1%+28.7%+0.4%
2018+1.2%+0.7%+0.5%
2017+28.0%+27.5%+0.4%
2016−10.4%−10.6%+0.2%

Source: Fund prospectus bar charts

Holdings overlap

24 of PRHSX's top 25 holdings also appear in JEHSX's top 25.

Shared top holdings
HoldingPRHSXJEHSX
Eli Lilly & Co14.28%14.30%
Johnson & Johnson6.63%6.33%
Unitedhealth Group Inc5.99%5.95%
Abbvie Inc5.10%5.28%
Merck & Co. Inc.4.01%4.21%
Gilead Sciences Inc2.82%2.95%
Thermo Fisher Scientific Inc2.52%2.67%
Vertex Pharmaceuticals Inc2.28%2.38%
Bristol-myers Squibb Co2.11%2.22%
Abbott Laboratories1.89%2.00%
Intuitive Surgical Inc1.87%1.98%
Amgen Inc1.82%1.90%
Stryker Corp1.78%1.87%
Elevance Health Inc1.53%1.63%
Natera Inc1.44%1.49%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

JEHSX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

FAQ

What is the difference between PRHSX and JEHSX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and JEHSX (Health Sciences Trust) have nearly the same top holdings — their top 25 positions are about 97% the same by weight. PRHSX is cheaper at 0.83% vs 1.04% — a difference of $21 a year per $10,000 invested.
Which is cheaper, PRHSX or JEHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and JEHSX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.